Ifosfamide Package Insert

Only IFOSFAMIDE INJECTION - Food And Drug Administration
Treatment with ifosfamide may cause myelosuppression and significant suppression of immune responses, which can lead to severe infections. Fatal outcomes of ifosfamide-associated myelosuppression have been reported. Ifosfamide-induced myelosuppression can cause leukopenia, neutropenia, thrombocytopenia ... View Full Source

Vasostrict - Par Sterile Products
Vasostrict [package insert]. Chestnut Ridge, NY: Par Pharmaceutical Companies, Inc.; 2016. * Vials may be held up to 12 months upon removal from refrigeration to room temperature storage conditions (20°C to 25°C [68°F to 77°F], ... Get Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION With A Fluoropyrimidine ...
3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Melanoma KEYTRUDA®(pembrolizumab) is indicated for the treatment of patients with unresectable or metastatic melanoma [see Clinical Studies (14.1)]. 1.2 Non-Small Cell Lung Cancer ... Fetch Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Ovarian Cancer GEMZAR®in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. ... Access This Document

Idamycin Idarubicin Hydrochloride For Injection, USP
IDAMYCIN (idarubicin hydrochloride for injection, USP) is intended for administration under the supervision of a physician who is experienced in leukemia chemotherapy. IDAMYCIN is a potent bone marrow suppressant. ... Return Document

Cyclophosphamide For Injection, USP
Cyclophosphamide for Injection, USP RX ONLY DESCRIPTION Cyclophosphamide for Injection, USP is a sterile white powder containing cyclophosphamide monohydrate. Cyclophosphamide is a synthetic antineoplastic drug chemically related to the nitrogen mustards. Cyclophosphamide is a white crystalline powder ... Access Doc

Reference ID: 3366104 - ZEVALIN
6. Transfer 1.3 mL of Zevalin (ibritumomab tiuxetan) to the reaction vial. Do not shake or agitate the vial contents. 7. Allow the labeling reaction to proceed at room temperature for 5 minutes. A shorter or longer reaction time may adversely alter the final labeled product. 8. ... Read Full Source

ToposarTM - Pfizer
TOPOSAR is contraindicated in patients who have demonstrated a previous hypersensitivity to it. WARNINGS Patients being treated with TOPOSAR must be frequently observed for myelosuppression both during and after therapy. Dose-limiting bone marrow suppression is the most significant toxicity associated with etoposide therapy. ... Access Full Source

DAUNORUBICIN HYDROCHLORIDE INJECTION Rx ONLY
DNOP-AQ-02 DAUNORUBICIN HYDROCHLORIDE INJECTION Rx ONLY WARNINGS 1. Daunorubicin Hydrochloride Injection must be given into a rapidly fl owing intravenous infusion. ... Retrieve Here

HA3001425 IFEX (Ifosfamide For Injection, USP) Package Insert
Title: HA3001425 IFEX (Ifosfamide for Injection, USP) Package Insert.pdf Author: marksm Created Date: 4/15/2015 2:01:21 PM ... Retrieve Document

L'idarubicine ou 4-déméthoxydaunorubicine est un anticancéreux de type anthracycline.Elle s'insère dans l'ADN et l'empêche de se dérouler en interférant avec l'enzyme topoisomérase II.C'est un analogue de la daunorubicine, mais l'absence de groupe méthoxy accroît sa Liposolubilité et son absorption cellulaire [3]. ... Read Article

Of 4-6 Cycles. Following Completion Of Chemotherapy ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Locally Advanced or Metastatic Urothelial Carcinoma TECENTRIQ (atezolizumab) is indicated for the treatment of patients with locally advanced or ... Retrieve Document

Treatment) First. - Food And Drug Administration
Treatment) first. • Prioritize injection of remaining lesion(s) based on lesion size until maximum injection volume is . reached or until all injectable . lesion(s) have been treated. ... Fetch This Document

AmBisome (amphotericin B) Liposome For Injection
3 Antimicrobial Activity AmBisome has shown in vitro activity comparable to amphotericin B against the following organisms: Aspergillus fumigatus, Aspergillus flavus, Candida albicans, Candida krusei, Candida lusitaniae, Candida parapsilosis, Candida ... Access Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION Interstitial Lung ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HYCAMTIN FOR INJECTION safely and effectively. ... Read Document

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
JANUVIA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adultswith type 2 diabetes mellitus. (1.1) Important Limitations of Use: JANUVIA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. (1.2) ... Read Document

DaunoXome - HemOnc.org
Therapy with DaunoXome is contraindicated in patients who have experienced a serious hypersensitivity reaction to previous doses of DaunoXome or to any of its constituents. WARNINGS DaunoXome is intended for administration under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents. ... View Doc

Reference ID: 3095352 - Food And Drug Administration
Ifosfamide neurotoxicity may become manifest within a few hours to a few days after first administration and in most cases resolves within 48 to 72 hours of ifosfamide discontinuation. Symptoms may persist for longer periods of time. Supportive therapy should be maintained until their complete resolution. Occasionally, recovery has been incomplete. ... Retrieve Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GLEEVEC safely and effectively. See full prescribing information for ... Access Doc